Skip Navigation Links.
Activity Information
Presentation
Diagnostic Evaluation
Folate Deficiency
Neural Tube Defects
Folic Acid Supplementation
Preconception Interventions
Summary
Follow-up
Preventing NTD
Preconception Interventions
References
Final Scoring Page
Evaluation
Claim Credit
Finish

Online CME Activity

Maximizing an Opportunity: Preconception Education for a 27-Year-Old Hispanic Woman Presenting for Annual Exam


Title:
Maximizing an Opportunity: Preconception Education for a 27-Year-Old Hispanic Woman Presenting for Annual Exam
Expiration Date:
09/09/2010
Topics:
Genetics, Sexual Health, Women's Health
Primary Audience:
Obstetricians/Gynecologists
Activity Format:
Patient Case Study
Credits:
2.00 AMA PRA Category 1 Credits™

 
Overall Satisfaction Rating:
Full Star Full Star Full Star Full Star Empty Star 84%

Learning Objective

Describe the role of adequate folate levels during the periconceptual period in preventing adverse birth outcomes.

Identify key points to discuss with female patients of reproductive age that relate to preconception folate counseling, including patients’ individual lifestyle and dietary habits.

Accreditation

This educational program is conceived and credited in accordance with ACCME's Essential Areas and Policies, including the 2004 Updated Standards for Commercial Support. Pri-Med faculty hail from a variety of institutions and participate in content development, along with Pri-Med Institute's Advisory Boards and its expert review partners, the University of Wisconsin School of Medicine and Public Health and Tufts Health Care Institute. All final decisions about program content are the responsibility of Pri-Med Institute.

Credits Type Accreditation Statement Designation Statement
2.00 AMA PRA Category 1 Credits™ Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Pri-Med Institute designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
View Additional Accreditation Information

Faculty and Editorial Board

Written By: Michele G. Curtis, MD, MPH, Associate Professor; Obstetrics, Gynecology, and Reproductive Sciences; University of Texas Medical School; Houston, Texas

Reviewed By: Alyce Kuklinski, MSN, RN, NP, Pri-Med Institute

Edited By: Carolyn Skowronski, PharmD

Financial Disclosure Statement(s)

Dr Curtis serves as a consultant for Novartis Pharmaceuticals and Novogyne. She is also a special government employee (consultant) for the Centers for Disease Control and Prevention.

Ms Kuklinski has no financial relationships to disclose.

Carolyn Skowronski holds stock in Merck & Co.

Education Partner:

Pri-Med Institute

Commercial Support:

Bayer HealthCare Pharmaceuticals

Pri-Med Disclaimer

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, or M|C Communications, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.